semaglutide and psoriatic arthritis GLP-1 drugs Ozempic, Zepbound, Mounjaro for Psoriasis and Glucagon-like peptide-1 receptor agonists in

A licensed healthcare provider will review your health history and goals to determine whether Wegovy may be a safe and suitable option for you

A half-unit error at 10 mg/mL changes your dose by 0.05 mg

We monitor your health to ensure your safety throughout your weight loss journey We do not require it for most patients, but you will sign a waiver stating you will see your primary care provider routinely to have blood work reviewed

Weight loss in those taking Wegovy puts the drug close to the 20% to 25% losses seen with bariatric surgery, said Stanford at Mass General, and well above the 3% to 4% seen with diet and other lifestyle changes alone

The medication has a half-life of about one week, which allows for weekly dosing, but skipping doses or inconsistent timing can create gaps in coverage where appetite suppression weakens, and blood sugar control falters